Skip to Content

2 Results Found

  • Article
  • Open Access
9 Citations
5,569 Views
27 Pages

Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse

  • Tamara L. Paget,
  • Emma J. Parkinson-Lawrence,
  • Paul J. Trim,
  • Chiara Autilio and ,
  • Madhuriben H. Panchal,
  • Grielof Koster,
  • Mercedes Echaide,
  • Marten F. Snel,
  • Anthony D. Postle and
  • Sandra Orgeig
  • + 7 authors+ 2 authors

8 April 2021

Mucopolysaccharidosis IIIA (MPS IIIA) is a lysosomal storage disease with significant neurological and skeletal pathologies. Respiratory dysfunction is a secondary pathology contributing to mortality in MPS IIIA patients. Pulmonary surfactant is cruc...

(This article belongs to the Special Issue Lysosomal Storage Disorders)
  • Article
  • Open Access
2 Citations
3,342 Views
22 Pages

Lung surfactant is a mixture of lipids and proteins and is essential for air breathing in mammals. The hydrophobic surfactant proteins B and C (SP-B and SP-C) assist in reducing surface tension in the lung alveoli by organizing the surfactant lipids....

(This article belongs to the Section Drug Discovery, Development and Delivery)